Biotech Catches Eye of Bill Gates

January 19, 2013 at 1:45 pm PT

For chief executives of startup biotechnology companies, traveling hat-in-hand to investor conferences in pursuit of new financing is an unrelenting task.

So it was a particularly good day for Michael Pellini, CEO of Foundation Medicine Inc., when an unsolicited query from Bill Gates popped up in his inbox last September.

The co-founder of Microsoft Corp. and global-health philanthropist had heard about Foundation’s new cancer diagnostic test and wanted more information about the company. The email didn’t mention any interest in investing in Foundation, and Dr. Pellini wasn’t actually looking for money—the company was poised to announce it had closed on a new round of financing. But Dr. Pellini wasted no time in responding.
Read the rest of this post on the original site »

Tagged with: Bill Gates, biotech, investing, Microsoft

Must-Reads from other Websites

Why Apple Should Buy China’s Xiaomi

Panos Mourdoukoutas, Contributor, Forbes

What I Didn’t Say

Paul Graham, Founder, ViaWeb

We Need to Talk About TED

Benjamin Bratton, Journalist, The Guardian

I, Glasshole: My Year With Google Glass

Mat Honan, Senior Writer, Wired

All Together Now

Chris Ware, Writer, The New Yorker

The Sculpture on the Moon

Corey S. Powell and Laurie Gwen Shapiro, Contributors, Slate

About Voices

Along with original content and posts from across the Dow Jones network, this section of AllThingsD includes Must-Reads From Other Websites — pieces we’ve read, discussions we’ve followed, stuff we like. Six posts from external sites are included here each weekday, but we only run the headlines. We link to the original sites for the rest. These posts are explicitly labeled, so it’s clear that the content comes from other websites, and for clarity’s sake, all outside posts run against a pink background.

We also solicit original full-length posts and accept some unsolicited submissions.